ANDREW GUINIGUNDO: Open Payments
NPI 1124083407 · CINCINNATI, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$26,841 in 78 payments from 15 companies in 2025. Trend: 2023 $39,413 · 2024 $41,655 · 2025 $26,841
Speaker / faculty: $18,814Travel & lodging: $6,028Food & beverage: $1,439Consulting: $480Education: $80
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 50 | $21,662 |
| AstraZeneca Pharmaceuticals LP | 11 | $4,094 |
| PFIZER INC. | 2 | $503 |
| Gilead Sciences, Inc. | 3 | $165 |
| Legend Biotech USA Inc. | 1 | $90 |
| SANOFI-AVENTIS U.S. LLC | 1 | $80 |
| Janssen Biotech, Inc. | 2 | $43 |
| GENZYME CORPORATION | 1 | $43 |
| JAZZ PHARMACEUTICALS INC. | 1 | $41 |
| Iovance Biotherapeutics, Inc. | 1 | $35 |
Products named: IMDELLTRA (AMG757), TAGRISSO, XTANDI, IMFINZI, Trodelvy, DATROWAY, LYNPARZA, SARCLISA.
Industry payments across OH — which companies pay providers there.
